TAKE ACTION TODAY
    PROTECT YOUR SAMPLES NOW
         OPTIMIZE YOUR DRUG’S CHANCES FOR SUCCESS
              DECREASE YOUR OPPORTUNITY RISK

• An Industry Working Group with Merck Research Laboratories, Biostorage Technologies and National Cancer Institute discussing the creating and adhering to standards for pharmaceutical and biotech biorepository operations to achieve high quality results and data.
• Roche Molecular Diagnostics discussing standardization across human specimen resources for optimal sample usage.

• The Keynote Address from Johnson & Johnson Pharmaceutical Research and Development and Eli Lilly & Company focusing on how to leverage your biorepository as a strategic asset to uncover new biomarkers and advance translational medicine.
• Helicos Biosciences Corporation addressing the future of healthcare and how critical a role biological samples play.

• 3 tracks on the operational strategies for Biorepositories with Eli Lilly, Biogen Idec and JB Matthew Consulting.
• Millenium Pharmaceuticals Inc. concentrating on maximizing sample integrity and utility while keeping pace with emerging technology and industry trends.

Richard Deane Hockett
Medical Fellow II, Director of Genomic Medicine at Eli Lilly and Company
ELI LILLY & COMPANY

• Jennifer Benner, Manager of Quality Systems, BioStorage Technologies, Inc.
• Andrew I. Brooks, Associate Professor of Environmental Medicine & Genetics, Rutgers University
• Nadine Cohen, Ph.D, Head of Pharmacogenomics and Senior Research Fellow, Johnson & Johnson Pharmaceutical Research and Development
• Crystal Dotson, Banking Process Expert/Diagnostic and Experimental Medicine, Eli Lilly & Company
• Lisa Fey BS, LATG, RQAP-GLP, Scientific Investigator, Bioanalytical Chemistry, Amylin Pharmaceuticals
• Mr. Edward (Ed) Paul Frantz, Jr., Director of National Sales, ENVIRONMENTAL SPECIALTIES (A LUWA GROUP COMPANY)
• Marylee Garvey, Senior Supervisor, Sample Management, Biogen Idec
• Jayne C Gershkowitz, Director of Patient Advocacy and Public Policy, Amicus Therapeutics
• Mr. Thomas (Tom) A. Herdman, Director of Engineering & Product Development, ENVIRONMENTAL SPECIALTIES (A LUWA GROUP COMPANY)
• Richard Deane Hockett, Medical Fellow II, Director of Genomic Medicine at Eli Lilly and Company, Eli Lilly & Company
• Diane Johnson, Associate Director, Pfizer's DNA & BioFluids Center of Emphasis
• Edward S. Kaercher, PMP®, Project Management Office, Merck & Co., Inc.
• Joseph Kessler, Associate Director, Vaccine & Biologics Research, Merck Research Laboratories
• Erik M. Koenig, Manager II, Molecular Technologies, Millennium Pharmaceuticals Inc.
• Jim Matthew, JB Matthew Consulting LLC, formerly Executive Director of Exploratory Medicinal Science, Pfizer
• Jon Merz, MBA, JD, PhD, Associate Professor, Center for Bioethics, University of Pennsylvania
• Dr F. John Mills, CEO, BioStorage Technologies, Inc.
• Patrice M. Milos, PhD, Vice President and Chief Scientific Officer, Helicos BioSciences Corporation
• Lisa Miranda, Technical Director, Tumor Tissue and Biospecimen Bank, University of Pennsylvania
• Helen M. Moore, PhD, Biospecimen Research Network Program Manager Office of the Director, National Cancer Institute
• Justin Owen, Head of Hardware Engineering, The Automation Partnership, UK
• Michele Piovella, PhD, MKT Manager, BioRep s.r.l.
• Karen Pitt, Special Assistant for Biological Resources, National Cancer Institute
• Dr. David Toke, Associate Managing Director, Rutgers University Cell and DNA Repository, (RUCDR)
• Amelia Wall Warner, PharmD, RPh, Senior Principal Scientist, Schering-Plough Corporation
• David Wellis, PhD , President & CEO, GenVault Corporation